Increased prefrontal cerebral blood flow in first-episode schizophrenia following treatment: Longitudinal positron emission tomography study

Australian and New Zealand Journal of Psychiatry

Volumn 41, Issue 2, 2007, Pages 129-135

  Brewer, Warrick J ^a   Yücel, Murat ^b   Harrison, Ben J ^b   McGorry, Patrick D ^a   Olver, James ^c   Egan, Gary F ^b   Velakoulis, Dennis ^b   Pantelis, Christos ^b  

^a ORYGEN RESEARCH CENTRE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c AUSTIN HOSPITAL   (Australia)

Author keywords

Cognitive interference; Follow up; Neuroleptic na ve; Prefrontal cortex; Schizophrenia

Indexed keywords

HALOPERIDOL; RISPERIDONE;

ADULT; ARTICLE; BRAIN BLOOD FLOW; BRAIN FUNCTION; BRAIN REGION; BRAIN SCINTISCANNING; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; LEARNING; MALE; PATIENT ATTITUDE; POSITIVE SYNDROME; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA; TASK PERFORMANCE;

ADULT; ANTIPSYCHOTIC AGENTS; CEREBROVASCULAR CIRCULATION; COGNITION DISORDERS; FOLLOW-UP STUDIES; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; POSITRON-EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; REACTION TIME; SCHIZOPHRENIA; SEVERITY OF ILLNESS INDEX;

EID: 34248182579     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.1080/00048670601109899     Document Type: Article

References (28)

1. Callicott, JH, Mattay, VS, Verchinski, BA, Marenco, S., Egan, MF and Weinberger, DR. (2003) Complexity of prefrontal cortical dysfunction in schizophrenia: More than up or down. Am J Psychiatry, 160, pp. 2209-2215.
2. Weinberger, DR, Berman, KF and Zec, RF. (1986) Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence. Arch Gen Psychiatry, 43, pp. 114-124.
3. Andreasen, NC, Rezai, K. and Alliger, R. (1992) Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Assessment with xenon 133 single-photon emission computed tomography and the Tower of London. Arch Gen Psychiatry, 49, pp. 943-958.
4. Yücel, M., Volker, C. and Collie, A. (2002) Impairments of response conflict monitoring and resolution in schizophrenia. Psychol Med, 32, pp. 1251-1260.
5. Perlstein, WM, Carter, CS, Noll, DC and Cohen, JD. (2001) Relation of prefrontal cortex dysfunction to working memory and symptoms in schizophrenia. Am J Psychiatry, 158, pp. 1105-1113.
6. Barch, DM, Carter, CS and Braver, TS (2001) Selective deficits in prefrontal cortex function in medication-naive patients with schizophrenia. Arch Gen Psychiatry, 58, pp. 280-288.
7. MacDonald, AW III and Carter, CS. (2003) Event-related FMRI study of context processing in dorsolateral prefrontal cortex of patients with schizophrenia. J Abnorm Psychol, 112, pp. 689-697.
8. MacDonald, AW III, Carter, CS and Kerns, JG (2005) Specificity of prefrontal dysfunction and context processing deficits to schizophrenia in never-medicated patients with first-episode psychosis. Am J Psychiatry, 162, pp. 475-484.
9. Harrison, BJ, Shaw, M. and Yucel, M. (2005) Functional connectivity during Stroop task performance. Neuroimage, 24, pp. 181-191.
10. Morey, RA, Inan, S., Mitchell, TV, Perkins, DO, Lieberman, JA and Belger, A. (2005) Imaging frontostriatal function in ultra-high-risk, early, and chronic schizophrenia during executive processing. Arch Gen Psychiatry, 62, pp. 254-262.
11. Snitz, BE, MacDonald, A III, Cohen, JD, Cho, RY, Becker, T. and Carter, CS. (2005) Lateral and medial hypofrontality in first-episode schizophrenia: Functional activity in a medication-naive state and effects of short-term atypical antipsychotic treatment. Am J Psychiatry, 162, pp. 2322-2329.
12. First, MB, Spitzer, RL, Gibbon, M. and Williams, JB. (1997) Structured Clinical Interview for DSM-IV Axis I Disorders, American Psychiatric Press, Washington, DC
13. McGorry, PD, Edwards, J., Mihalopoulos, C., Harrigan, SM and Jackson, HJ. (1996) EPPIC: An evolving system of early detection and optimal management. Schizophr Bull, 22, pp. 305-326.
14. Stroop, R. (1935) Studies of interference in serial verbal reactions. J Exp Psychol, 18, pp. 643-662.
15. Kay, SR, Opler, LA, Spitzer, RL, Williams, JB, Fiszbein, A. and Gorelick, A. (1991) SCID-PANSS: Two-tier diagnostic system for psychotic disorders. Compr Psychiatry, 32, pp. 355-361.
16. Kay, SR, Opler, LA, Spitzer, RL, Williams, JB, Fiszbein, A. and Gorelick, A. (1991) SCID-PANSS: Two-tier diagnostic system for psychotic disorders. Compr Psychiatry, 32, pp. 355-361.
17. Harrison, BJ, Yücel, M. and Shaw, M. (2006) Dysfunction of dorsolateral prefrontal cortex in antipsychotic-naïve schizophreniform psychosis. Psychiatry Res Neuroimaging, 148, pp. 23-31.
18. Nelson, HE and O'Connell, A. (1978) Dementia: The estimation of premorbid intelligence levels using the New Adult Reading Test. Cortex, 14, pp. 234-244.
19. Yücel, M., Pantelis, C. and Stuart, GW (2002) Anterior cingulate activation during Stroop task performance: A PET to MRI coregistration study of individual patients with schizophrenia. Am J Psychiatry, 159, pp. 251-254.
20. Yücel, M., Stuart, GW and Maruff, P. (2002) Paracingulate morphologic differences in males with established schizophrenia: A magnetic resonance imaging morphometric study. Biol Psychiatry, 52, pp. 15-23.
21. Honey, GD, Bullmore, ET, Soni, W., Varatheesan, M., Williams, SC and Sharma, T. (1999) Differences in frontal cortical activation by a working memory task after substitution of risperidone for typical antipsychotic drugs in patients with schizophrenia. Proc Natl Acad Sci USA, 96, pp. 13 432-13 437.
22. Liddle, PF, Friston, KJ, Frith, CD and Frackowiak, RS. (1992) Cerebral blood flow and mental processes in schizophrenia. J R Soc Med, 85, pp. 224-227.
23. Keefe, RS, Silva, SG, Perkins, DO and Lieberman, JA. (1999) The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: A review and meta-analysis. Schizophr Bull, 25, pp. 201-222.
24. Kapur, S. (2003) Psychosis as a state of aberrant salience: A framework linking biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiatry, 160, pp. 13-23.
25. Wager, TD, Sylvester, CY, Lacey, SC, Nee, DE, Franklin, M. and Jonides, J. (2005) Common and unique components of response inhibition revealed by fMRI. Neuroimage, 27, pp. 323-340.
26. Bush, G., Luu, P. and Posner, MI. (2000) Cognitive and emotional influences in anterior cingulate cortex. Trends Cogn Sci, 4, pp. 215-222.
27. Green, MF, Marder, SR and Glynn, SM (2002) The neurocognitive effects of low-dose haloperidol: A two-year comparison with risperidone. Biol Psychiatry, 51, pp. 972-978.
28. Fagerlund, B., Mackeprang, T., Gade, A. and Glenthoj, BY. (2004) Effects of low-dose risperidone and low-dose zuclopenthixol on cognitive functions in first-episode drug-naive schizophrenic patients. CNS Spectr, 9, pp. 364-374.